Anti-Obesity Effect of Pediococcus Pentosaceus LP28

Hiroshima University

Status: Completed

Conditions: Obesity

Treatments: Dietary Supplement: Live Pediococcus pentosaceus LP28; Dietary Supplement: Placebo; Dietary Supplement: Heat-killed Pediococcus pentosaceus LP28

Study type: Interventional

Funder types: Other

Identifiers

NCT01685944

eki-619

Details and patient eligibility

About

This study is designed to evaluate efficacy of Pediococcus pentosaceus LP28 in reducing body fat and body weight in subjects with BMI 25-30 kg/m2.

Enrollment: 62 patients

Sex: All

Ages: 20 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• BMI 25-30 kg/m2

Exclusion criteria

• Taking medicines or functional food that may affect body weight or body fat
• Pregnant or nursing a child
• Participation in any clinical trial within 90 days of the commencement of the trial
• Renal or hepatic dysfunction
• Heart disease

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

62 participants in 3 patient groups, including a placebo group

Placebo

Placebo Comparator group

Treatment:

Dietary Supplement: Placebo

Live Pediococcus pentosaceus LP28

Experimental group

Treatment:

Dietary Supplement: Live Pediococcus pentosaceus LP28

Heat-killed Pediococcus pentosaceus LP28

Experimental group

Treatment:

Dietary Supplement: Heat-killed Pediococcus pentosaceus LP28